Related references
Note: Only part of the references are listed.Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Pablo Tebas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
Nadine G. Rouphael et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk
Scott D. Neidich et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
Esper G. Kallas et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Nicole L. Yates et al.
JOURNAL OF VIROLOGY (2018)
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial
Marnie L. Elizaga et al.
PLOS ONE (2018)
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E. Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung et al.
CELL (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals
Matthew P. Morrow et al.
MOLECULAR THERAPY (2015)
COMPASS identifies T-cell subsets correlated with clinical outcomes
Lin Lin et al.
NATURE BIOTECHNOLOGY (2015)
Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials
Xia Jin et al.
VACCINE (2015)
Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device
Dinah H. Amante et al.
HUMAN GENE THERAPY METHODS (2015)
OMIP-025: Evaluation of Human T- and NK-Cell Responses Including Memory and Follicular Helper Phenotype by Intracellular Cytokine Staining
Gemma Moncunill et al.
CYTOMETRY PART A (2015)
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
Paul A. Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
Susan Zolla-Pazner et al.
PLOS ONE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
Spyros A. Kalams et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion
S. Munir Alam et al.
JOURNAL OF VIROLOGY (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tolerability of intramuscular and intradermal delivery by CELLECTRA® adaptive constant current electroporation device in healthy volunteers
Malissa C. Diehl et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
Mark L. Bagarazzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
High-Throughput Quantitative Analysis of HIV-1 and SIV-Specific ADCC-Mediating Antibody Responses
Justin Pollara et al.
CYTOMETRY PART A (2011)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Simultaneous Evaluation of the Magnitude and Breadth of a Left- and Right-Censored Multivariate Response, With Application to HIV Vaccine Development
Yunda Huang et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2009)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination
Helen Horton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials
Marta Bull et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
Fusheng Li et al.
VACCINE (2006)
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help
MA Kutzler et al.
JOURNAL OF IMMUNOLOGY (2005)
Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice
MA Chattergoon et al.
VACCINE (2004)